Skip to main content
. 2004 Jun 28;4:10. doi: 10.1186/1471-2377-4-10

Table 5.

Recurrence rates according treatment group.

Treatment Recurrence Rate n/N (%)
RI 11/22 (50%)
RI + RO 6/39 (15.4%)
RI + TA 2/26 (7.7%)
P value P < 0.01 for RI vs RI + RO
P < 0.01 for RI vs RI + TA
P = NS for RI + RO vs RI + TA

RI: rizatriptan; RO: rofecoxib; TA: tolfenamic acid; n: attacks where recurrence were observed; N: number of treated attacks.